Clinical Trial Update: High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating high-dose chemotherapy with peripheral stem cell transplantation and interleukin-2 for acute myeloid leukemia has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• High-dose chemotherapy (high-dose chemotherapy)
• Interleukin-2 (interleukin-2)
• Peripheral stem cell transplantation

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Leukemia | Phase 3 | Status: COMPLETED